Orthokeratology Lens Market Forecast, Size Analysis, Industry Outlook, & Region Forecast Till 2030

 


Orthokeratology Lens Market Forecast, Revenue, Competitive Landscape, Growth Factors, and Trends: Information by Material (Silicone Acrylate, Fluorosilicone Acrylate and Fluorocarbon Acrylate), Application (Myopia and Hyperopia), End User (Hospitals and Ophthalmic Clinic) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa)

The Global Orthokeratology Lens Market size is expected to register a CAGR of7.4% during the forecast period with a market value of USD 3,857.8 Million till 2025. Orthokeratology is also known as ortho-k, corneal refractive therapy (CRT), and overnight vision correction therapy. In the orthokeratology therapy, rigid gas permeable contact lenses are worn overnight that reshapes the curvature of the cornea to improve object visibility. The use of ortho-k lenses eliminates the need for daytime contact lenses or glasses and improves vision.

The increasing advancements in the field of ophthalmology over the past couple of decades, low cost compared to laser-assisted in situ keratomileuses (LASIK) treatment is anticipated to drive the market growth. However, the risk associated with orthokeratology and availability of alternative treatment methods is likely to hamper the market growth.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8218

Segment Analysis

The global orthokeratology lens market is segmented into material, application, and end user. By material, has been segmented into silicone acrylate, fluorosilicone acrylate, and fluorocarbon acrylate. On the basis of application, the global orthokeratology lens market has been segmented into myopia and hyperopia. Based on end user, the market has been segmented into hospitals and ophthalmic clinic.

Regional Analysis

The global orthokeratology lens market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to hold the largest share of the global orthokeratology lens market. This is owing to the increasing healthcare infrastructure, growing geriatric population suffering from ophthalmological disorders, and rising health demand for the treatment for eye disorders are boosting the market growth in this region.

The Asia-Pacific market holds the second-largest position in the global orthokeratology lens market owing to the increasing patient population of people with eye disorders, availability of progressive treatment facilities, and increasing healthcare expenditure by the Asian population is driving the market growth in this region. According to the Asian Development Bank, the elderly population in Asia is projected to reach nearly 923 million by 2050. Such an increase in the number of the geriatric population drives the market.

Followed by Asia-Pacific, Europe stood the third-largest market. The presence of a large number of medical device companies and adaption of innovative technology to develop new products are contributing to the market growth of this region. According to the Journal of Ophthalmology, as of 2014, there were around 28 million visually impaired people in the European region. Moreover, according to the United Kingdom Statistics Authority, around 121,736 eye examinations were performed under the Eye Health Examinations Wales (EHEW) scheme in 2016. These cases of eye disorders and rising government initiatives are driving the growth of the market.

The orthokeratology lens market in the Middle East & Africa is expected to grow due to the rising awareness about eye treatments coupled with gradually increasing adoption of medical diagnosis modalities in the region.

Market Players

MRFR recognizes the following companies as the key players in the global orthokeratology lens market— Bausch & Lomb Incorporated (US), CooperVision (US), CE GP Specialists (US), Menicon Co., Ltd (Japan), Procornea (CooperVision) (Eerbeek, Netherlands), Euclid Systems Corporation (Virginia), Visioneering Technologies, Inc. (VTI) (Georgia), Brighten Optix (Taiwan), Alcon, Inc. (Texas) and CONTAMAC (Essex).

Key Findings of the Study

  • The Global Orthokeratology Lens Market was valued at USD 2,353.7 million in 2018, is estimated to grow at USD 3,857.8 million by 2025 at a CAGR of 7.4% during the assessment period
  • Americas accounted for the largest share of the global market due to the presence of key market players and an increasing patient population in the US and Canada
  • Based on application, the myopia segment accounted for the largest market share of in 2018
  • Based on the material, the silicone acrylate segment held a major market value of USD 1,331.4 million in 2018
  • On the basis of the end user, the hospitals dominated the market and accounted for a share of 1,319.3 million in 2018

Access Report Details @ https://www.marketresearchfuture.com/reports/orthokeratology-lens-market-8218

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Digital Pathology Market Research, Size, Revenue, Trends, Competitive Landscape Study & Analysis, Forecast To 2028

Image
  The growing number of innovations in the areas of pathology would further increase the size of the market to a great deal, in the next six years. According to MRFR, the Digital Pathology Market is expected to register a CAGR of 6.5% over the review period from 2021 to 2028 and expected to reach USD 1.4 Billion by 2028. Digital Pathology or Computational Pathology leverages completely new perceptions through data analysis, enabling pathologists to consult on treatment options. The rapidly evolving pathology sector is a key element of modern diagnostic practices. There have been several innovations and widespread adoption of digital pathology. It has long been realized that the traditional histopathology is inefficient as it exposes samples to various handlers, increasing the scope for human error. The digital pathology, on the other hand, eliminates the risk factors, while also providing the pathologist with the necessary images and clinical information to generate the most a...
Read more

Structural Heart Devices Market Size, Key Player Revenue, SWOT, PEST & Porter’s Analysis Till 2027

Image
Structural heart diseases   are problems associated with the valves or tissues of the heart. These diseases may be congenital or might be acquired later in life. Structural heart diseases include cardiomyopathy, myocarditis, aortic valve stenosis, heart valve disease, atrial septal defect, mitral valve regurgitation, and others. As per the latest report of Market Research Future (MRFR), the structural heart devices market is poised to expand at CAGR of 10.4% over the forecast period. The  structural heart devices market  is primarily driven by a radical rise in the incidence rate of non-coronary heart disorders, increased demand for minimally invasive surgical procedures, and improving reimbursement schemes. In the past few years, tremendous advances have been achieved with respect to the understanding of these diseases, and accordingly, therapeutic modalities have been developed. A number of clinical trials and technology developments are underway, which is likely to pro...
Read more

Anal Fissure Treatment Market Competitive Landscape, Growth Factors, Revenue Analysis Till 2030

Image
  The global  anal fissure treatment market  is expected to rise and touch a valuation of USD 2,526.5 million by 2023, at a 7.6% CAGR during the forecast period. Anal fissures are small tears near the mucosal lining of the anus. Deeper cuts may take a combination of oral and topical medicine to alleviate the pain. The anal fissure treatment market is expected to thrive owing to the booming pediatric and geriatric patient pool. Advances in technology coupled with various treatment options is likely to lead to a windfall for the market over the forecast period. High incidence of constipation is predicted to drive the need for anal fissure treatments. This is backed by vulnerability of the elderly which find it difficult to pass stools properly. According to the American Gastroenterological, nearly 33% of Americans above 60 experience the condition. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3841 Unhealthy lifestyles adopted by pat...
Read more